Pulmonx (LUNG) Proxy filing summary

Executive summary

• The annual meeting is scheduled for June 4, 2026, to be held virtually, with voting on director elections, auditor ratification, and executive compensation.

• Shareholders of record as of April 7, 2026, are entitled to vote, with 42,237,203 shares outstanding.

• Voting can be done online, by phone, or by mail, and shareholders are encouraged to vote in advance.

Voting matters and shareholder proposals

• Three Class III directors are nominated for election to serve until 2029.

• Ratification of BDO USA, LLP as the independent auditor for fiscal year 2026 is proposed.

• A non-binding advisory vote on executive compensation (say-on-pay) is included.

• Shareholder proposals for the 2027 meeting must be submitted by December 23, 2026.

Board of directors and corporate governance

• The board consists of seven members divided into three classes with staggered three-year terms.

• Six of seven directors are independent; the CEO is not considered independent.

• The board has an independent chair and three standing committees: Audit, Compensation, and Nominating and Corporate Governance.

• Board diversity is emphasized, with 28% female and 14% from underrepresented communities.

• Directors are subject to a stock ownership policy to align interests with shareholders.